Search

Author/Creator Daar, Eric S

1. 1063. Female sex and SARS-CoV-2 Serostatus Predict Nasopharyngeal RNA Clearance during Early COVID-19. (15th December 2022)

Authors:
Moser, Carlee; Li, Jonathan Z; Eron, Joseph J; Aga, Evgenia; Daar, Eric S; Wohl, David A; Coombs, Robert; Javan, Arzhang Cyrus; Bender Ignacio, Rachel A; Jagannathan, Prasanna; Ritz, Justin; Sieg, Scott; Parikh, Urvi; Hughes, Michael D; Currier, Judith S; Smith, Davey M; Chew, Kara W
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 536Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs) Comparing Initial Non-Nucleoside Reverse-Transcriptase Inhibitor (NNRTI)- versus Ritonavir Boosted Protease Inhibitor (PI/r)-based Anti-Retroviral Therapy (ART). (December 2014)

Authors:
Borges, Álvaro H; Lundh, Andreas; Tendal, Britta; Huedo-Medina, Tania B; Bartlett, John a; Costagliola, Dominique; Clumeck, Nathan; Daar, Eric S; Dejesus, Edwin; Echeverría, Patricia; Gisslén, Magnus; Honda, Miwako; Hughes, Michael; Khabo, P; Komati, Stephanus; Kumar, Princy N.; Lockman, Shahin; ...
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 878. Association between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death for Non-Hospitalized Adults with Mild-to-Moderate COVID-19. (15th December 2022)

Authors:
Giganti, Mark; Chew, Kara W; Eron, Joseph J; Li, Jonathan Z; Pinilla, Mauricio; Moser, Carlee; Javan, Arzhang Cyrus; Fischer, William A; Klekotka, Paul; Margolis, David A; Wohl, David A; Coombs, Robert; Daar, Eric S; Smith, Davey M; Hughes, Michael D; Currier, Judith S
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 881. Nasal and Plasma SARS-CoV-2 RNA Levels Predict Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19. (15th December 2022)

Authors:
Li, Yijia; Harrison, Linda J; Chew, Kara W; Eron, Joseph J; Daar, Eric S; Wohl, David A; Wu, Ryan; Moser, Carlee; Ritz, Justin; Giganti, Mark; Javan, Arzhang Cyrus; Coombs, Robert; Hughes, Michael D; Currier, Judith S; Smith, Davey M; Li, Jonathan Z
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens. (March 2015)

Authors:
Broglio, Kristine R; Daar, Eric S; Quintana, Melanie; Yuan, Yong; Kalsekar, Anupama; Spellberg, Brad; Lewis, Roger J; Akker, Dan Van Den; Detry, Michelle A; Le, Trong; Berry, Scott M
Journal:
Journal of comparative effectiveness research
Issue:
Volume 4:Number 2(2015)
Page Start:
101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Issue 10107 (4th November 2017)

Authors:
Gallant, Joel; Lazzarin, Adriano; Mills, Anthony; Orkin, Chloe; Podzamczer, Daniel; Tebas, Pablo; Girard, Pierre-Marie; Brar, Indira; Daar, Eric S; Wohl, David; Rockstroh, Jürgen; Wei, Xuelian; Custodio, Joseph; White, Kirsten; Martin, Hal; Cheng, Andrew; Quirk, Erin
Journal:
Lancet
Issue:
Volume 390:Issue 10107(2017)
Page Start:
2063
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor–Containing Regimens. (17th October 2020)

Authors:
Leonard, Michael A; Cindi, Zinhle; Bradford, Yuki; Bourgi, Kassem; Koethe, John; Turner, Megan; Norwood, Jamison; Woodward, Beverly; Erdem, Husamettin; Basham, Rebecca; Baker, Paxton; Rebeiro, Peter F; Sterling, Timothy R; Hulgan, Todd; Daar, Eric S; Gulick, Roy; Riddler, Sharon A; Sinxadi, Phuml...
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 7(2021)
Page Start:
e2153
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial. Issue 7 (July 2018)

Authors:
Daar, Eric S; DeJesus, Edwin; Ruane, Peter; Crofoot, Gordon; Oguchi, Godson; Creticos, Catherine; Rockstroh, Jürgen K; Molina, Jean-Michel; Koenig, Ellen; Liu, Ya-Pei; Custodio, Joseph; Andreatta, Kristen; Graham, Hiba; Cheng, Andrew; Martin, Hal; Quirk, Erin
Journal:
Lancet
Issue:
Volume 5:Issue 7(2018)
Page Start:
e347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗